Sponsored Content
Sponsored Content
Friday, 28 May
Saturday, 29 May
Sunday, 30 May
Monday, 31 May
Tuesday, 1 June
10:00 - 16:00 (TBC) |
Pre-Congress Day Symposium for Physiotherapists supported by Roche |
7:30 - 8:30 |
Breakfast Seminar supported by LFB Biomedicaments New insights in the use of intravenous immunoglobulins : How to enhance CIDP patient's clinical outcomes? |
13:30 - 14:30 |
Luncheon Seminar supported by Santhera Respiratory management in DMD |
13:30 - 14:30 |
Luncheon Seminar supported by Sarepta Therapeutics Charting a Course for Gene Transfer in Neuromuscular Disorders: The Basics, The Data and How to Prepare |
13:30 - 14:30 |
Luncheon Seminar supported by Takeda IG with MMN or CIDP |
13:30 - 14:30 |
Luncheon Seminar supported by Sanofi Genzyme Pompe disease diagnosis and management |
13:30 - 14:30 |
Luncheon Seminar supported by Biogen Evolving landscape in the management of neuromuscular disease: Review advances in the management of neuromuscular disease with focus on spinal muscular atrophy and amyotrophic lateral sclerosis, the role of genetic testing and therapies that may modify the disease |
18:30 - 19:30 |
Evening Seminar supported by Fulcrum |
18:30 - 19:30 |
Evening Seminar supported by argenx Myasthenia Gravis: The Role of FcRn Blockade in IgG Regulation |
7:30 - 8:30 |
Breakfast Seminar supported by Lupin Neurosciences Myotonia Inside Out: an update on pathology, treatment and clinical management of NDM |
7:30 - 8:30 |
Breakfast Seminar supported by UCB Biopharma |
|
13:30 - 14:30 |
Luncheon Seminar supported by Roche In my Shoes... through Natural History data we learn the meaningful outcomes in SMA |
 13:30 - 14:30 Salon Multiuso 1 A+C |
Luncheon Seminar supported by Alexion Complement Inhibition in Myasthenia Gravis |
 13:30 - 14:30 Salon Multiuso 1 A+C |
Luncheon Seminar supported by Novartis Gene Therapies Clinical and Practical Considerations for Gene Therapy in Spinal Muscular Atrophy |
 13:30 - 14:30 Auditorio 2 |
Luncheon Seminar supported by PTC Symposium on Duchenne Muscular Dystrophy |
-
The ICNMD is organized on behalf of the Applied Research Group on Neuromuscular Diseases of the World Federation of Neurology. -
ICNMD2021 Conference Secretariat
ICS International Conference Services LTD (ICS)
300 – 1201 West Pender Street
Vancouver, BC, Canada V6E 2V2
P: [+1] 604 681 2153
E: icnmd2021@icsevents.com
Web: icnmd.org
